Contract facts
FederalNo full NAICS 541990 intel page yet. Browse NAICS intelligence
Fiscal Year 2023 Breast Cancer Research Program Vision Setting, Pre-Application Screening, Programmatic Review and Gene… is a federal award for Army Med Res Acq Activity held by Leidos, Inc. Estimated value $1.2M ($785K obligated). Current period of performance ends Feb 22, 2024. Place of performance: FREDERICK MD. Related solicitation W81XWH22R0025.
Fiscal year 2023 breast cancer research program vision setting, pre-application screening, programmatic review and general program support. Latest action is a modification.
Recompete timing
PublicCurrent PoP ended Feb 22, 2024 (972 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on HT942523F0048? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordLeidos, Inc — $3.2B obligated across 1,081 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT942523F0048?
HT942523F0048 (Fiscal year 2023 breast cancer research) is a Army Med Res Acq Activity award with a potential value of $1.2M, currently held by Leidos, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT9425-23-F-0048?
HT9425-23-F-0048 is the dashed form of PIID HT942523F0048 (Fiscal year 2023 breast cancer research), held by Leidos, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT942523F0048?
Army Med Res Acq Activity awarded HT942523F0048 to Leidos, Inc (potential $1.2M).
Who is the incumbent on HT942523F0048?
Leidos, Inc is the incumbent with $3.2B across 1081 related awards in SCOUT’s public footprint. The current period of performance ends Feb 22, 2024.
When does Leidos, Inc’s HT942523F0048 come up for recompete?
SCOUT tracks a period-of-performance end of Feb 22, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on HT942523F0048? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.